Section - CAP Smart Prend

01. Rémission et rechute dans le trouble obsessionnel-compulsif pédiatrique

Publié sur 1 avril 2024 Certification date d'expiration: 1 avril 2027

Lorena Rodríguez, M.D.

Assistant Editor - Psychopharmacology Institute

Points Clés

Despite initial response levels, continued treatment can lead to remission in many pediatric patients with OCD, emphasizing the need for perseverance in management strategies.
Certain subtypes like hoarding OCD may be more resistant to standard therapies, necessitating innovative therapeutic approaches.

Pour débloquer cet audio vous avez besoin de devenir un Silver, Gold, Silver extended, Gold extended, Gold – fr, Silver – fr, Silver extended – fr ou Gold extended – fr Membre.

Consultez Notre Programme d'ÉMC

Téléchargements pour un Accès Hors ligne

Télécharger Fichier Audio (MP3)

Version texte

Bonjour, ici David Rosenberg. Dans ce « CAP Smart Take », nous allons examiner un domaine souvent négligé, mais crucial, de la pédopsychiatrie : la rémission et la rechute au cours du suivi à long terme — plus précisément, un suivi de trois ans — de patients pédiatriques ayant reçu un diagnostic de trouble obsessionnel-compulsif (TOC). Cette étude est remarquable à bien des égards.

Les auteurs ont étudié les taux de rémission et de rechute sur une période de trois ans chez des patients pédiatriques atteints de TOC et traités selon les protocoles thérapeutiques les plus avancés, incluant la thérapie cognitivo-comportementale (TCC) en première intention. Si nécessaire, les patients poursuivaient la TCC ou recevaient de la sertraline en seconde intention. Ils ont analysé un vaste échantillon de près de 270 patients répondant aux critères du DSM-IV pour le TOC. Le score moyen à l’échelle d’évaluation du TOC chez l’enfant (CY-BOCS)

Le déblocage de cette CAP Smart Take et gagner de 0.50 CMEs
Devenir un Silver, Gold, Silver extended, Gold extended, Gold – fr, Silver – fr, Silver extended – fr ou Gold extended – fr Membre.

Obtenez L'Accès Instantané

Avez déjà un compte? Signe dans

La Section Suivante

02. Efficacité des probiotiques dans le traitement des symptômes du TDAH

Learning Objectives:

Recognize that at 3-year follow-up, 3 in 4 pediatric patients with OCD were in clinical remission.
Recognize that although not statistically significant, combining probiotics with methylphenidate was associated with higher therapeutic efficacy in patients with ADHD.
Analyze the effectiveness of ECT in treating adolescents with severe depressive episodes and suicidality.
Recognize that studies to date support the safety of transcranial electrical stimulation and transcranial magnetic stimulation in children and adolescents.
Recognize that escitalopram was not superior to placebo for relapse prevention in adolescents with MDD.

Original Release Date: April 1, 2024

Expiration Date: April 1, 2027

Experts: David Rosenberg, M.D.

Medical Editor: Lorena Rodriguez, M.D.

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@ml-staging.psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

View the required educational content provided on this course page.
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.